Zeying Du, M.D., Ph.D.

  1. Laboratory Immunologist
  1. Du Z, Williams CD. Full genomic sequence of the HLA-DQB1*06:18:01 allele identified by next-generation sequencing. HLA 2024 Aug; 104 (2):e15664
    View PubMed
  2. Du Z, Murrin ME, Patel PB, Williams CD, Elrefaei M. Identification of the novel HLA-DQA1*05:101 allele by next-generation sequencing in a family. HLA. 2024 Mar; 103 (3):e15443
    View PubMed
  3. Du Z, Williams C, Santiago R, Ussery T, Elrefaei M. Identification of the novel HLA-B*57:168 allele by next generation sequencing. HLA. 2024 Jan; 103 (1):e15327 Epub 2023 Dec 11
    View PubMed
  4. Du Z, Williams C, Robinson T, Hardage B, Elrefaei M. Identification of the novel HLA-C*03:648 allele by next generation sequencing. HLA. 2024 Jan; 103 (1):e15324 Epub 2023 Dec 11
    View PubMed
  5. Raz R, Patel J, Du Z. STRONG HLA CLASS I ANTIBODY PRODUCTION AFTER SARS-COV-2 VACCINATION AND INFECTION: A CASE REPORT Hum Immunol. 2022; 83(Suppl):70.
  6. Chang A, Moore JM, Cowan ML, Josephson MA, Chon WJ, Sciammas R, Du Z, Marino SR, Meehan SM, Millis M, David MZ, Williams JW, Chong AS. Plasma cell densities and glomerular filtration rates predict renal allograft outcomes following acute rejection. Transpl Int. 2012 Oct; 25 (10):1050-8 Epub 2012 July 17
    View PubMed
  7. Bonagura VR, Du Z, Ashouri E, Luo L, Hatam LJ, DeVoti JA, Rosenthal DW, Steinberg BM, Abramson AL, Gjertson DW, Reed EF, Rajalingam R. Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis. Hum Immunol. 2010 Feb; 71 (2):212-9 Epub 2009 Oct 25
    View PubMed
  8. Du Z, Chang A, Josephson MA, Marino SR. HLA class II antibodies in kidney transplant patients are associated with severe allograft histopathology and graft dysfunction. 2010 (S4): 415. Am J Transplant. 2010; (S4):415.
  9. Du Z, Sharma SK, Spellman S, Reed EF, Rajalingam R. KIR2DL5 alleles mark certain combination of activating KIR genes. Genes Immun. 2008 Jul; 9 (5):470-80 Epub 2008 May 29
    View PubMed
  10. Levinson RD, Du Z, Luo L, Holland GN, Rao NA, Reed EF, Rajalingam R. KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease. Hum Immunol. 2008 Jun; 69 (6):349-53 Epub 2008 May 09
    View PubMed
  11. Rajalingam R, Du Z, Meenagh A, Luo L, Kavitha VJ, Pavithra-Arulvani R, Vidhyalakshmi A, Sharma SK, Balazs I, Reed EF, Pitchappan RM, Middleton D. Distinct diversity of KIR genes in three southern Indian populations: comparison with world populations revealed a link between KIR gene content and pre-historic human migrations. Immunogenetics. 2008 May; 60 (5):207-17 Epub 2008 Mar 28
    View PubMed
  12. Levinson RD, Du Z, Luo L, Monnet D, Tabary T, Brezin AP, Zhao L, Gjertson DW, Holland GN, Reed EF, Cohen JH, Rajalingam R. Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals. Genes Immun. 2008 Apr; 9 (3):249-58 Epub 2008 Mar 13
    View PubMed
  13. Rajalingam R, Du Z, Luo L, et al. Direct sequencing analyses revealed the group-B haplotypes- associated KIR genes are relatively conserved in Caucasians. Hum Immunol. 2008; 69(Suppl):s6.
  14. Luo L, Du Z, Sharma SK, Cullen R, Spellman S, Reed EF, Rajalingam R. Chain-terminating natural mutations affect the function of activating KIR receptors 3DS1 and 2DS3. Immunogenetics. 2007 Oct; 59 (10):779-92 Epub 2007 July 24
    View PubMed
  15. Du Z, Gjertson DW, Reed EF, Rajalingam R. Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans. Immunogenetics. 2007 Jan; 59 (1):1-15 Epub 2006 Nov 14
    View PubMed
  16. Veale JL, Liang LW, Zhang Q, Gjertson DW, Du Z, Bloomquist EW, Jia J, Qian L, Wilkinson AH, Danovitch GM, Pham PT, Rosenthal JT, Lassman CR, Braun J, Reed EF, Gritsch HA. Noninvasive diagnosis of cellular and antibody-mediated rejection by perforin and granzyme B in renal allografts. Hum Immunol. 2006 Oct; 67 (10):777-86 Epub 2006 Aug 04
    View PubMed
  17. Du ZY, Li XY, Li YC, Wang SY. Analysis of triptolide-regulated gene expression in Jurkat cells by complementary DNA microarray. Acta Pharmacol Sin. 2003 Sep; 24 (9):864-72
    View PubMed
  18. Liang L, Zhang Q, Du ZY, et al. Non-invasive immune monitoring of perforin/ granzyme B and anti- HLA antibodies predicts renal allograft rejection. Am J Transplant. 2003; 3(S5):359.
  19. Jin YP, Singh RP, Du ZY, Rajasekaran AK, Rozengurt E, Reed EF. Ligation of HLA class I molecules on endothelial cells induces phosphorylation of Src, paxillin, and focal adhesion kinase in an actin-dependent manner. J Immunol. 2002 Jun 1; 168 (11):5415-23
    View PubMed
  20. Du ZY, Li XY. Inhibitory effects of indomethacin on interleukin-1 and nitric oxide production in rat microglia in vitro. Int J Immunopharmacol. 1999 Mar; 21 (3):219-25
    View PubMed
  21. Du ZY, Li XY, Ye QZ. The structure features and inhibitors for tumor necrosis factor-alpha. Shen Li Ke Xue Jin Zhan. 1999; 30(3):242-245.
    View PubMed
  22. Du ZY, Li XY. Effects of ginkgolides on interleukin-1, tumor necrosis factor-alpha and nitric oxide production by rat microglia stimulated with lipopolysaccharides in vitro. Arzneimittelforschung. 1998 Dec; 48 (12):1126-30
    View PubMed
  23. Du ZY, Li XY. Inhibitory effects of ginkgolides on nitric oxide production in neonatal rat microglia in vitro. Zhongguo Yao Li Xue Bao. 1998 Sep; 19 (5):467-70
    View PubMed
  24. Du ZY, Li XY. The relationship between immunoinflammatory reactions and Alzheimer’s disease. Shen Li Ke Xue Jin Zhan. 1998; 29(3):253-256.
    View PubMed
  25. Du ZY, Li XY. Cytokine and nitric oxide production by rat microglia stimulated with lipopolysaccharides in vitro. Zhongguo Yao Li Xue Bao. 1998 May; 19 (3):257-60
    View PubMed
  26. Du ZY, Liu XJ. Clinical significance to monitor plasma soluble interleukin-2 receptor level in cyclosporine A-treated renal transplant patients. Chin J Hospital Pharm. 1995; 15(1):3-5.
  27. Du ZY, Liu XJ, Wang SY. Dual regulation of lentinan on IL-2 secretion and IL-2 receptor expression on human lymphocytes. Chin J Exp Clin Immunol. 1994; 40-3.
  28. Du ZY, Huang YH. Effects of tetrandrine on production of leukotriene B4 and thromboxane B2 in rabbit blood. Zhongguo Yao Li Xue Bao. 1993 Jul; 14 (4):325-8
    View PubMed
  29. Du ZY, Huang YH. Leukotriene B4 receptors. Shen Li Ke Xue Jin Zhan. 1990; 21(4):340-4.
    View PubMed
  30. Du ZY, Huang YH, Ou-Yang Y. Effects of tetrandrine on the metabolism of arachidonic acid in rabbit polymorph nuclear leukocytes. Acta Med Mil Ter. 1990; 12(3):291-294.
  31. Ou-Yang Y, Du ZY, Shang JC. The whole blood model to study the effects of drug on the biosynthesis of leukotriene B4 in rabbit. Chin Pharmacol Bull. 1990; 6(3):228.
  32. Shang JC, Ou-Yang Y, Du ZY. The solid phase extraction and reverse-phase high performance liquid chromatography determination of leukotriene in biological samples. J Chongqing Univ Med Sci. 1990; 15(2):198-202.